secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pelthos Therapeutics Inc. (PTHS)
CIK:        0001919246
Form:       8-K
Filed at:   2026-05-28T21:01:24+00:00
Accession:  0001919246-26-000085
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pelthos Therapeutics CEO to present at Jefferies conference; no material news disclosed
--------------------------------------------------------------------------------

- CEO Scott Plesha will present at 11:05 a.m. ET on June 4, 2026 at the Jefferies Global Healthcare Conference in New York.
- The company will also hold one-on-one investor meetings at the conference.
- No financial results, guidance, or other material corporate developments were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1919246/000191924626000085/0001919246-26-000085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1919246/000191924626000085/pths-20260528.htm
  HTML page:      https://secwatch.observer/filing/0001919246-26-000085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer